Labcorp deploys new SARS-CoV-2 sequencing panel

By LabPulse.com staff writers

Labcorp will start using Molecular Loop Biosciences' SARS-CoV-2 research sequencing panel to sequence thousands of complete coronavirus genomes each week from positive patient samples.

The panel converts extracted RNA samples into sequencer-ready libraries in four steps to make it easy to implement and scale for Illumina or PacBio sequencing. Redundant probe tiling technology means emerging variants are detected and the concern about amplicon or allele dropouts that can occur in amplicon-based workflows is alleviated.

The sequencing is part of a U.S. Centers for Disease Control and Prevention (CDC) initiative to identify and track the spread of SARS-CoV-2 variants throughout the country.


Copyright © 2021 LabPulse.com
 

To read this and get access to all of the exclusive content on LabPulse.com, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a LabPulse.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?